综合一区欧美国产,99国产麻豆免费精品,九九精品黄色录像,亚洲激情青青草,久久亚洲熟妇熟,中文字幕av在线播放,国产一区二区卡,九九久久国产精品,久久精品视频免费

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Latest

Virologist: Lab leakage claims pure fabrication

By ZHANG ZHIHAO | chinadaily.com.cn | Updated: 2020-05-26 21:00
Share
Share - WeChat

Research under pressure

Despite these safety guarantees, Yuan said the recent onslaught of conspiracy theories against the institute has brought great pressure to the researchers who are busy studying the virus and looking for a possible cure or vaccine.

"I believe it would be hard for anyone to be completely indifferent to such suspicions, rumors and even malicious, offensive remarks that are pulled out of thin air," he said.

One rumor that was particularly toxic claimed that a female postgraduate student from the institute was the "patient zero" for COVID-19. "The student had graduated in 2015, and has been working and living a normal life in another city," Yuan said. But the rumor did "irreparable damage" to her safety and privacy and that of her family, he added.

"Despite unexpected pressure and stress, my colleagues and I clearly know that defeating this virus is our top priority and responsibility, and we have worked day in and day out without holidays or weekends," he said. "Our hard work has been fully supported by Wuhan residents and the government and is recognized by the international scientific community."

The institute is conducting research on the basic biological characteristics of the novel coronavirus and its mechanism of infection, as well as drug screening and vaccine development.

The Wuhan institute, along with the Shanghai Institute of Materia Medica and ShanghaiTech University, discovered compounds with new structures that can effectively inhibit the coronavirus. The results were published online in the journal Science on April 23.

An inactivated vaccine jointly developed by the Wuhan Institute of Biological Products Co and the Wuhan Institute of Virology was approved by the National Medical Products Administration of China on April 12 and was put into clinical trials the same day.

"It is the policy of the WIV to share scientific research information in an open and timely manner," Yuan said. "The P4 lab is an indispensable support platform for these efforts.

"Conducting systematic and in-depth research on a new virus that is so cunning and hard to counter urgently requires closer communication and cooperation among international peers."

|<< Previous 1 2 3   
Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
岳池县| 郯城县| 平昌县| 长宁区| 永济市| 精河县| 隆德县| 五指山市| 江华| 吴旗县| 成武县| 芦溪县| 香格里拉县| 肇州县| 海盐县| 彭泽县| 德庆县| 宁津县| 陆良县| 勃利县| 西充县| 梅河口市| 连城县| 鄂州市| 澄江县| 金溪县| 宣恩县| 岳阳市| 永定县| 扎鲁特旗| 车险| 鄂尔多斯市| 鄂托克旗| 五家渠市| 莫力| 岳普湖县| 乐亭县| 靖远县| 云浮市| 绩溪县| 吴川市|